Victoria Gibson1, Stephanie Needham2, Manu Nayer1, Nick P Thompson1. 1. Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK. 2. Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Abstract
OBJECTIVE: To determine whether development of localised protocol could reduce the number of non-targeted gastric biopsies taken at endoscopy, without risking harm from non-detection of malignant conditions. DESIGN: Retrospective analysis of patient records over a 3-month period in 2013, repeated in 2015 following intervention. SETTING: Two UK teaching hospitals. PATIENTS: Patient record data on indication for endoscopy, endoscopy findings, histopathology results and patient outcome. INTERVENTIONS: Guidance on upper gastrointestinal biopsy in the form of a new trust-wide protocol, as well as lecture-based education. MAIN OUTCOME MEASURES: Rates of non-targeted and targeted biopsies before and after intervention, and differences between grade of endoscopist. RESULTS: Between 2013 and 2015, there was a 36% reduction in non-targeted biopsies (10.4% vs 6.7%, p=0.001), predominantly within registrar and nurse endoscopist groups, with reduction in non-targeted biopsies of 9.5% and 64%, respectively. Percentage of targeted biopsies remained relatively static, 7.9% and 8.2%. In 2013, 92% of non-targeted biopsies had no management change based on histology; in 2015 this was 90%. Of patients with alteration to management, only 0.4% and 0.7% were due to malignancy, in known high-risk patients. Reduction in non-targeted biopsies resulted in estimated annual savings in this trust of £36,000. CONCLUSION: Development of local protocol reduces the numbers of non-targeted biopsies taken, without risk of harm from non-detection of malignant conditions, enabling a significant reduction in workload within busy histopathology services, with significant cost savings. Localised protocols are adaptable to local population demographics.
OBJECTIVE: To determine whether development of localised protocol could reduce the number of non-targeted gastric biopsies taken at endoscopy, without risking harm from non-detection of malignant conditions. DESIGN: Retrospective analysis of patient records over a 3-month period in 2013, repeated in 2015 following intervention. SETTING: Two UK teaching hospitals. PATIENTS: Patient record data on indication for endoscopy, endoscopy findings, histopathology results and patient outcome. INTERVENTIONS: Guidance on upper gastrointestinal biopsy in the form of a new trust-wide protocol, as well as lecture-based education. MAIN OUTCOME MEASURES: Rates of non-targeted and targeted biopsies before and after intervention, and differences between grade of endoscopist. RESULTS: Between 2013 and 2015, there was a 36% reduction in non-targeted biopsies (10.4% vs 6.7%, p=0.001), predominantly within registrar and nurse endoscopist groups, with reduction in non-targeted biopsies of 9.5% and 64%, respectively. Percentage of targeted biopsies remained relatively static, 7.9% and 8.2%. In 2013, 92% of non-targeted biopsies had no management change based on histology; in 2015 this was 90%. Of patients with alteration to management, only 0.4% and 0.7% were due to malignancy, in known high-risk patients. Reduction in non-targeted biopsies resulted in estimated annual savings in this trust of £36,000. CONCLUSION: Development of local protocol reduces the numbers of non-targeted biopsies taken, without risk of harm from non-detection of malignant conditions, enabling a significant reduction in workload within busy histopathology services, with significant cost savings. Localised protocols are adaptable to local population demographics.
Authors: Raf Bisschops; Miguel Areia; Emmanuel Coron; Daniela Dobru; Bernd Kaskas; Roman Kuvaev; Oliver Pech; Krish Ragunath; Bas Weusten; Pietro Familiari; Dirk Domagk; Roland Valori; Michal F Kaminski; Cristiano Spada; Michael Bretthauer; Cathy Bennett; Carlo Senore; Mário Dinis-Ribeiro; Matthew D Rutter Journal: United European Gastroenterol J Date: 2016-08-21 Impact factor: 4.623
Authors: J Williams; I Russell; D Durai; W-Y Cheung; A Farrin; K Bloor; S Coulton; G Richardson Journal: Health Technol Assess Date: 2006-10 Impact factor: 4.014
Authors: Jun Liang Teh; Jin Rong Tan; Linus Jian Fa Lau; Nakul Saxena; Agus Salim; Amy Tay; Asim Shabbir; Sydney Chung; Mikael Hartman; Jimmy Bok-Yan So Journal: Clin Gastroenterol Hepatol Date: 2014-08-10 Impact factor: 11.382